These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22161814)

  • 1. Suppression assays with human T regulatory cells: a technical guide.
    McMurchy AN; Levings MK
    Eur J Immunol; 2012 Jan; 42(1):27-34. PubMed ID: 22161814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of peripheral tolerance and immune regulation mediated by Treg.
    Sakaguchi S; Wing K; Yamaguchi T
    Eur J Immunol; 2009 Sep; 39(9):2331-6. PubMed ID: 19662638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and expansion of baboon CD4+CD25+ Treg cells for potential use in a non-human primate xenotransplantation model.
    Porter CM; Horvath-Arcidiacono JA; Singh AK; Horvath KA; Bloom ET; Mohiuddin MM
    Xenotransplantation; 2007 Jul; 14(4):298-308. PubMed ID: 17669171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A CFSE based assay for measuring CD4+CD25+ regulatory T cell mediated suppression of auto-antigen specific and polyclonal T cell responses.
    Venken K; Thewissen M; Hellings N; Somers V; Hensen K; Rummens JL; Stinissen P
    J Immunol Methods; 2007 Apr; 322(1-2):1-11. PubMed ID: 17368474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid assessment of in vitro expanded human regulatory T cell function.
    Ruitenberg JJ; Boyce C; Hingorani R; Putnam A; Ghanekar SA
    J Immunol Methods; 2011 Sep; 372(1-2):95-106. PubMed ID: 21781972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An optimized CFSE-based T-cell suppression assay to evaluate the suppressive capacity of regulatory T-cells induced by human tolerogenic dendritic cells.
    Boks MA; Zwaginga JJ; van Ham SM; ten Brinke A
    Scand J Immunol; 2010 Aug; 72(2):158-68. PubMed ID: 20618775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTLA-4 (CD152) controls homeostasis and suppressive capacity of regulatory T cells in mice.
    Kolar P; Knieke K; Hegel JK; Quandt D; Burmester GR; Hoff H; Brunner-Weinzierl MC
    Arthritis Rheum; 2009 Jan; 60(1):123-32. PubMed ID: 19116935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysfunction of CD4+CD25high T regulatory cells in patients with recurrent aphthous stomatitis.
    Lewkowicz N; Lewkowicz P; Dzitko K; Kur B; Tarkowski M; Kurnatowska A; Tchórzewski H
    J Oral Pathol Med; 2008 Sep; 37(8):454-61. PubMed ID: 18318707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of regulatory T cell development and suppressive function.
    Kim JM
    Prog Mol Biol Transl Sci; 2010; 92():279-314. PubMed ID: 20800825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometry-based methods for studying signaling in human CD4+CD25+FOXP3+ T regulatory cells.
    Crellin NK; Garcia RV; Levings MK
    J Immunol Methods; 2007 Jul; 324(1-2):92-104. PubMed ID: 17582431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
    Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
    J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNF activates a NF-kappaB-regulated cellular program in human CD45RA- regulatory T cells that modulates their suppressive function.
    Nagar M; Jacob-Hirsch J; Vernitsky H; Berkun Y; Ben-Horin S; Amariglio N; Bank I; Kloog Y; Rechavi G; Goldstein I
    J Immunol; 2010 Apr; 184(7):3570-81. PubMed ID: 20181891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural regulatory T cells: mechanisms of suppression.
    Miyara M; Sakaguchi S
    Trends Mol Med; 2007 Mar; 13(3):108-16. PubMed ID: 17257897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo.
    Delgado M; Chorny A; Gonzalez-Rey E; Ganea D
    J Leukoc Biol; 2005 Dec; 78(6):1327-38. PubMed ID: 16204628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer.
    Kiniwa Y; Miyahara Y; Wang HY; Peng W; Peng G; Wheeler TM; Thompson TC; Old LJ; Wang RF
    Clin Cancer Res; 2007 Dec; 13(23):6947-58. PubMed ID: 18056169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice.
    Qu Y; Zhang B; Zhao L; Liu G; Ma H; Rao E; Zeng C; Zhao Y
    Transpl Immunol; 2007 Apr; 17(3):153-61. PubMed ID: 17331841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta: an important role in CD4+CD25+ regulatory T cells and immune tolerance.
    Zhang L; Yi H; Xia XP; Zhao Y
    Autoimmunity; 2006 Jun; 39(4):269-76. PubMed ID: 16891215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of CFSE to monitor ex vivo regulatory T-cell suppression of CD4+ and CD8+ T-cell proliferation within unseparated mononuclear cells from malignant and non-malignant human lymph node biopsies.
    Hilchey SP; Bernstein SH
    Immunol Invest; 2007; 36(5-6):629-48. PubMed ID: 18161522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional assay for human CD4+CD25+ Treg cells reveals an age-dependent loss of suppressive activity.
    Tsaknaridis L; Spencer L; Culbertson N; Hicks K; LaTocha D; Chou YK; Whitham RH; Bakke A; Jones RE; Offner H; Bourdette DN; Vandenbark AA
    J Neurosci Res; 2003 Oct; 74(2):296-308. PubMed ID: 14515359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza matrix 1-specific human CD4+ FOXP3+ and FOXP3(-) regulatory T cells can be detected long after viral clearance.
    Piersma SJ; van der Hulst JM; Kwappenberg KM; Goedemans R; van der Minne CE; van der Burg SH
    Eur J Immunol; 2010 Nov; 40(11):3064-74. PubMed ID: 20821728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.